e.l.f. Beauty and its executives are looking to fend off a securities lawsuit accusing them of misleading investors about demand and inventory trends, including by presenting demand as stronger than it was while inventory increased. In a newly filed answer, the company pushes back, denying that its statements were false or misleading, asserting that key metrics were publicly disclosed, and framing the plaintiffs’ claims as an attempt to recast disclosed business conditions – and a subsequent slowdown in growth – as actionable fraud.
The Background in Brief: The case was filed in the U.S. District Court for the Northern District of California in March 2025, with a group of investors waging securities fraud claims against e.l.f. Beauty and certain executives, including (collectively, “e.l.f.”). The plaintiffs allege that e.l.f. made false or misleading statements about demand, claiming the company “falsely told investors that demand was as strong as ever” even as growth slowed. The plaintiffs – two retirement systems – seek to represent investors who purchased e.l.f. stock during the relevant period and claim they were harmed when the company later issued weaker guidance and its stock price declined.
The case was narrowed in February, with the court dismissing the bulk of the challenged statements and allowing only a limited set of claims – tied primarily to statements by the company’s CEO in late 2024 – to proceed.
Inside e.l.f.’s Defense Playbook
In an answer filed on April 3, e.l.f. not only denies the allegations against it but also asserts a series of affirmative defenses addressing issues of falsity, reliance, price impact, and good faith. Among the most significant is truth on the market, an affirmative defense that can preclude claims that investors were misled where the relevant information was already publicly available. The defense aligns with e.l.f.’s emphasis that it “publicly discloses its inventory levels” and had previously alerted investors that it was “build[ing] back [its] inventory.” Here, e.l.f. is effectively arguing that the inventory data that the plaintiffs rely on was publicly disclosed, thereby undercutting their theory that the market was misled.
e.l.f. also invokes the PSLRA safe harbor, preserving the argument that any challenged forward-looking statements may be non-actionable. In doing so, the company is preserving the position that statements about expected demand or growth may be protected if they qualify as forward-looking and were accompanied by appropriate cautionary language.
The company further raises no reliance and no price impact defenses, which address whether investors relied on the alleged misstatements and whether those statements affected e.l.f.’s stock price.
Finally, e.l.f. pushes back on scienter-related allegations through both denials and affirmative defenses, including a good-faith defense for the individual defendants, arguing that they should not be held personally liable under Section 20(a) because they acted in good faith. At the same time, e.l.f. disputes the plaintiffs’ insider trading theory, asserting that the cited stock sales by its executives were made “solely to satisfy tax or other government withholding obligations” tied to the vesting of equity awards and were executed pursuant to its compensation plans.
THE BOTTOM LINE: Taken together, e.l.f.’s defenses position the case as turning on whether the challenged statements were actually false, whether the underlying inventory data was already disclosed to the market, and whether plaintiffs can show that any alleged misstatements affected e.l.f.’s stock price or give rise to liability for the individual defendants.
The case is In re e.l.f. Beauty, Inc. Securities Litigation, 5:25-cv-02316 (N.D. Cal.)
Share
